Fish Oil May Raise or Lower Colon Cancer Risk, Depending on Your Genes
WEDNESDAY, Sept. 24, 2025 — About 19 million U.S. adults take fish oil supplements, often to protect against chronic diseases. But new research suggests their ability to lower colon cancer risk may depend on a single gene.
Scientists at the University of Michigan and the University of Texas MD Anderson Cancer Center found that the gene 15-lipoxygenase-1 (ALOX15) is critical for omega-3 fatty acids in fish oil (EPA and DHA) to fight colon cancer.
The study — recently published in the journal Cellular and Molecular Gastroenterology and Hepatology — showed that without ALOX15, fish oil could actually raise the risk of colon tumors in mice.
“Not all fish oil supplements are the same,” senior researcher Imad Shureiqi, professor of internal medicine at the University of Michigan Rogel Cancer Center in Ann Arbor, said in a news release.
“It is also important to ask whether the person who is taking the supplement has the required enzymes to metabolize these products to prevent chronic inflammation and subsequently cancer development,” he added.
Researchers compared mice fed fish oil diets with mice on control diets. To their surprise, fish oil increased colon tumors in mice exposed to chemicals that cause inflammation and speed tumor formation.
That’s because the omega-3 fatty acids need ALOX15 to be broken down into anti-inflammatory molecules called resolvins, researchers explained. Chronic inflammation is a major factor in cancer.
The study showed:
-
Mice missing ALOX15 developed more colon tumors when given fish oil.
-
EPA seemed to work better than DHA, with fewer tumors seen in EPA-fed mice.
-
The type of supplement also mattered: Lovaza, an government-approved fish oil drug, and other EPA-based forms reduced tumor numbers and sizes in mice with ALOX15. But DHA products were less effective.
While results of animal studies often differ in humans, but these findings suggest fish oil may not protect everyone equally, especially folks without ALOX15.
The research team is working on drugs that could boost the presence of ALOX15 in cancer cells, making EPA and DHA supplements more effective at fighting cancer.
For now, experts recommend patients talk with their doctors before taking fish oil.
Sources
- Michigan Medicine - University of Michigan, news release, Sept. 23, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Drug-Resistant 'Nightmare Bacteria' Infections Soar 70% in U.S.
WEDNESDAY, Sept. 24, 2025 — Infections caused by bacteria that no longer respond to many antibiotics are climbing at an alarming pace in the U.S., new federal data...
Illinois Confirms First Case of Rare Tick-Borne Powassan Virus
WEDNESDAY, Sept. 24, 2025 — Illinois health officials are warning residents to be on alert after the state’s first case of Powassan virus was confirmed in a resident...
Women With Dense Breasts Benefit From Advanced Cancer Screening Procedures
WEDNESDAY, Sept. 24, 2025 — Women with dense breasts could benefit from an advanced cancer screening procedure called molecular breast imaging (MBI), a new study says. The...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.